Operator Good morning, and welcome to the Oatly fourth-quarter 2024 earnings conference call. [Operator instructions] Please note, this event is being recorded. I would now like to turn the conference ...
It's that time again! Pitchers and catchers are starting to report for spring training, so it's time to dive into my rankings ...
UCB, a global biopharmaceutical company, today announced long-term data from the BE HEARD^ trials for BIMZELX®â–¼ (bimekizumab) in moderate to severe hidradenitis suppurativa (HS). These two-year data, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback